pemafibrate

Term ID

CHEBI:228365

Synonyms

(2R)-2-[3-({1,3-benzoxazol-2-yl[3-(4-methoxyphenoxy)propyl]amino}methyl)phenoxy]butanoic acid
(2R)-2-[3-[[2-benzoxazolyl[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid
(R)-2-[3-[[N-(benzoxazol-2-yl)-N-[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid
(R)-K 13675
(R)-K-13675
K 877
K-877
K877
Parmodia

(all 9)

Definition

A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-amine in which the amino hydrogens are replaced by 3-[(1R)-1-carboxypropoxy]benzyl and 3-(4-methoxyphenoxy)propyl groups. It is a selective peroxisome proliferator-activated receptor (PPAR)-alpha agonist that is used for the treatment of hyperlipidaemia.

References

(all 47)

Ontology

ChEBI ( EBI )

Relationships

is a type of: 1,3-benzoxazoles aromatic amine methoxybenzenes monocarboxylic acid tertiary amino compound

1,3-benzoxazoles aromatic amine methoxybenzenes monocarboxylic acid tertiary amino compound Show first 5 Terms
has_role: antilipemic drug hepatoprotective agent PPARalpha agonist

antilipemic drug hepatoprotective agent PPARalpha agonist Show first 5 Terms

Phenotype

Phenotype resulting from pemafibrate

Phenotype where environments contain pemafibrate

Phenotype modified by environments containing pemafibrate

Phenotype affecting pemafibrate

Human Disease Model